News Sentiment

PGNY sentiment intelligence

Progyny Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 59 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Healthcare Plans Read-through group
Latest close 30.65 Week of 10 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+1.4% over one week, +15.1% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Progyny (PGNY) Stock May Be 50% Undervalued On Fresh Analyst Upgrades

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 1.4% Price digesting
Trend fit Trend active 15.1% over four weeks
Fair value 18.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 27
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
simplywall.st 8
TradingView 6
Stock Titan 2
The Globe and Mail 2
Stock Traders Daily 2
Sahm 2
The Motley Fool 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 18
Analyst action 8
Capital return 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-52 of 52
TradingView Direct company coverage

Progyny, Inc. Stock 12‑Month Price Target Raised to $30.4, Implies 13% Upside

Progyny, Inc.'s average 12-month price target has increased from $30 to $30.4, based on estimates from 10 analysts, with a range of $27 to $33 per share. This updated target suggests a potential upside of approximately 13% from the June 24 closing price. The consensus rating for

Tone
Positive 70/100
Event
Analyst action
Published
25 Jun 2026 04:12
Source
TradingView
Investing.com Direct company coverage

Form 4 Progyny Inc For: 23 June By Investing.com

This article from Investing.com announces the filing of Form 4 for Progyny Inc. on June 23. It states that Progyny's stock symbol is PGNY and lists its performance with a 1.33% increase. The article itself simply serves as a brief notice of the financial filing.

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 20:39
Source
Investing.com
Stock Titan Direct company coverage

Progyny (PGNY) Chief Product Officer has 819 shares withheld for RSU taxes

Progyny, Inc.'s Chief Product Officer, Geoffrey Clapp, had 819 shares of common stock withheld on June 17, 2026, to cover tax obligations related to the vesting of his restricted stock units. The shares were valued at $26.60 each for tax purposes, and this transaction was a routi

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 19:39
Source
Stock Titan
TradingKey Direct company coverage

Progyny Inc (PGNY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Progyny Inc (PGNY), focusing on its business segments and regional contributions. For the fiscal year 2025, the company's revenue was primarily driven by fertility benefits services, accounting for 64.48%, and pharmacy benefi

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 03:39
Source
TradingKey